Autism

The Trump administration is expected to unveil new efforts on Monday examining whether one widely used drug may be linked to autism and whether another could help treat it, according to people familiar with the plans who spoke to The Washington Post on condition of anonymity because the...

Health Secretary Robert F. Kennedy Jr. is preparing to release a report suggesting that the use of a common over-the-counter pain reliever during pregnancy may be tied to a higher risk of autism. Tylenol-maker KVUE stock is dropping. See the price action here. Tylenol-Autism Link? The report...

Researchers have submitted more than 100 proposals to join the Trump administration's $50 million Autism Data Science Initiative, with as many as 25 grants slated for award by late September, according to people familiar with the plans. NIH Details Scope, Timeline And Program Goals The National...

Health and Human Services Secretary Robert F. Kennedy Jr. said Tuesday he is on track to identify "interventions" that are "certainly causing autism" and to outline possible ways to address them by September, after President Donald Trump pressed him for an update during a Cabinet meeting. Robert...

The U.S. Centers for Disease Control and Prevention (CDC) is reportedly preparing to conduct a large-scale study examining potential links between vaccines and autism despite extensive research that has consistently found no credible evidence connecting vaccines to the condition. Long before COVID-...

In his upcoming memoir, Microsoft co-founder and philanthropist Bill Gates suggests that he may be neurodivergent, stating that if he were a child today, he would likely be diagnosed on the autism spectrum. What Happened: As revealed in an excerpt published by The Wall Street Journal, Gates...

In a recent development, the conversation around Sam Bankman-Fried’s sentencing has taken a new turn with discussions about his autism diagnosis and its potential impact on his legal consequences. What Happened: Eric Garcia discussed in an op-ed on MSNBC the complex issue of Bankman-Fried...

Cannformatics, an early-stage biotechnology company, has unveiled a groundbreaking advancement in the field of medical cannabis treatment for Autism Spectrum Disorder (ASD). Their recent publication in Nature's Scientific Reports highlights the use of Cannabis-Responsive (C-Res) biomarkers and...

Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE) presented data from the Phase 2 BRIGHT trial of Zygel in children and adolescents with autism spectrum disorder (ASD) over a longer-term, 38-week treatment period. Zygel is cannabidiol formulated in a transdermal gel.  The data were...

Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE), a company that focuses on treating rare and near-rare neuropsychiatric disorders through cannabinoid therapies, said Tuesday it received a new U.S. patent for one of its cannabis-focused treatments. Zynerba said the U.S. Patent and Trademark Office...